{"id":"https://openalex.org/W7225829708","doi":"https://doi.org/10.3389/fddsv.2026.1986902","title":"The highly G protein-biased mu opioid agonist displays buprenorphine-like efficacy in primates","display_name":"The highly G protein-biased mu opioid agonist displays buprenorphine-like efficacy in primates","publication_year":2026,"publication_date":"2026-11-11","ids":{"openalex":"https://openalex.org/W7225829708","doi":"https://doi.org/10.3389/fddsv.2026.1986902"},"language":"en","primary_location":{"id":"doi:10.3389/fddsv.2026.1986902","doi":"https://doi.org/10.3389/fddsv.2026.1986902","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fddsv.2026.1986902","pdf_url":null,"source":{"id":"https://openalex.org/S4210199683","display_name":"Frontiers in Drug Discovery","issn_l":"2674-0338","issn":["2674-0338"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Drug Discovery","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3389/fddsv.2026.1986902","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076524696","display_name":"Haani Jafri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134769","display_name":"University of Pittsburgh Medical Center","ror":"https://ror.org/04ehecz88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098814","https://openalex.org/I4210134769"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Haani Jafri","raw_affiliation_strings":["Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh Medical Center","institution_ids":["https://openalex.org/I4210134769"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161422382","display_name":"Huiping Ding","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405269449","display_name":"Wake Forest University Health Sciences","ror":"https://ror.org/046r1r105","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4405269449","https://openalex.org/I47251452"]},{"id":"https://openalex.org/I47251452","display_name":"Wake Forest University","ror":"https://ror.org/0207ad724","country_code":"US","type":"education","lineage":["https://openalex.org/I47251452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Huiping Ding","raw_affiliation_strings":["Academic Office of Informatics, Clinical and Translational Science Institute, Wake Forest University School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Office of Informatics, Clinical and Translational Science Institute, Wake Forest University School of Medicine","institution_ids":["https://openalex.org/I4405269449","https://openalex.org/I47251452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080747360","display_name":"Norikazu Kiguchi","orcid":"https://orcid.org/0000-0001-5401-8650","observed_orcids":["https://orcid.org/0000-0001-5401-8650"]},"institutions":[{"id":"https://openalex.org/I190805021","display_name":"Wakayama Medical University","ror":"https://ror.org/005qv5373","country_code":"JP","type":"education","lineage":["https://openalex.org/I190805021"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Norikazu Kiguchi","raw_affiliation_strings":["Department of Physiological Sciences, School of Pharmaceutical Sciences, Wakayama Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Physiological Sciences, School of Pharmaceutical Sciences, Wakayama Medical University","institution_ids":["https://openalex.org/I190805021"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110301017","display_name":"Dehui\ufffd Zhang","orcid":"https://orcid.org/0009-0004-9804-696X","observed_orcids":["https://orcid.org/0009-0004-9804-696X"]},"institutions":[{"id":"https://openalex.org/I180297670","display_name":"RTI International","ror":"https://ror.org/052tfza37","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I137902535","https://openalex.org/I170897317","https://openalex.org/I180297670"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dehui Zhang","raw_affiliation_strings":["Research Triangle Institute, Research Triangle Park"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Triangle Institute, Research Triangle Park","institution_ids":["https://openalex.org/I180297670"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161465301","display_name":"Yanan Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180297670","display_name":"RTI International","ror":"https://ror.org/052tfza37","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I137902535","https://openalex.org/I170897317","https://openalex.org/I180297670"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yanan Zhang","raw_affiliation_strings":["Research Triangle Institute, Research Triangle Park"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Triangle Institute, Research Triangle Park","institution_ids":["https://openalex.org/I180297670"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5158722880","display_name":"Mei-Chuan Ko","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mei-Chuan Ko","raw_affiliation_strings":["Department of Psychiatry, University of Pittsburgh School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, University of Pittsburgh School of Medicine","institution_ids":["https://openalex.org/I170201317"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5076524696"],"corresponding_institution_ids":["https://openalex.org/I4210134769"],"apc_list":{"value":1950,"currency":"CHF","value_usd":2353},"apc_paid":{"value":1950,"currency":"CHF","value_usd":2353},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.5570999979972839,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.5570999979972839,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.26829999685287476,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.08470000326633453,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C2776401185","wikidata":"https://www.wikidata.org/wiki/Q5204254","display_name":"DAMGO","level":5,"score":0.9483000040054321},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.777999997138977},{"id":"https://openalex.org/C2778949969","wikidata":"https://www.wikidata.org/wiki/Q407721","display_name":"Buprenorphine","level":4,"score":0.776199996471405},{"id":"https://openalex.org/C14397066","wikidata":"https://www.wikidata.org/wiki/Q14911924","display_name":"\u03bc-opioid receptor","level":4,"score":0.7163000106811523},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5918999910354614},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.5454999804496765},{"id":"https://openalex.org/C2777389121","wikidata":"https://www.wikidata.org/wiki/Q81225","display_name":"Morphine","level":2,"score":0.5450000166893005},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4781999886035919},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.47440001368522644},{"id":"https://openalex.org/C2778903686","wikidata":"https://www.wikidata.org/wiki/Q60168","display_name":"Heroin","level":3,"score":0.44339999556541443},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4390999972820282},{"id":"https://openalex.org/C2779886867","wikidata":"https://www.wikidata.org/wiki/Q421797","display_name":"Opioid receptor","level":4,"score":0.43689998984336853},{"id":"https://openalex.org/C2780509455","wikidata":"https://www.wikidata.org/wiki/Q7380","display_name":"Primate","level":2,"score":0.42969998717308044},{"id":"https://openalex.org/C2777972943","wikidata":"https://www.wikidata.org/wiki/Q409587","display_name":"Naltrexone","level":4,"score":0.3894999921321869},{"id":"https://openalex.org/C88016717","wikidata":"https://www.wikidata.org/wiki/Q417189","display_name":"Opioid peptide","level":4,"score":0.3862999975681305},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.35190001130104065},{"id":"https://openalex.org/C2778539182","wikidata":"https://www.wikidata.org/wiki/Q4693408","display_name":"Agonist-antagonist","level":4,"score":0.32440000772476196},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.32249999046325684},{"id":"https://openalex.org/C38533456","wikidata":"https://www.wikidata.org/wiki/Q1671589","display_name":"Intrinsic activity","level":4,"score":0.32010000944137573},{"id":"https://openalex.org/C2779012664","wikidata":"https://www.wikidata.org/wiki/Q424009","display_name":"Diprenorphine","level":5,"score":0.3197000026702881},{"id":"https://openalex.org/C2777803847","wikidata":"https://www.wikidata.org/wiki/Q325101","display_name":"Enkephalin","level":4,"score":0.3140000104904175},{"id":"https://openalex.org/C2776030879","wikidata":"https://www.wikidata.org/wiki/Q309200","display_name":"Squirrel monkey","level":2,"score":0.3059999942779541},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.28760001063346863},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2718999981880188},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.271699994802475}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3389/fddsv.2026.1986902","doi":"https://doi.org/10.3389/fddsv.2026.1986902","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fddsv.2026.1986902","pdf_url":null,"source":{"id":"https://openalex.org/S4210199683","display_name":"Frontiers in Drug Discovery","issn_l":"2674-0338","issn":["2674-0338"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Drug Discovery","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3389/fddsv.2026.1986902","doi":"https://doi.org/10.3389/fddsv.2026.1986902","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fddsv.2026.1986902","pdf_url":null,"source":{"id":"https://openalex.org/S4210199683","display_name":"Frontiers in Drug Discovery","issn_l":"2674-0338","issn":["2674-0338"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Drug Discovery","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":46,"referenced_works":["https://openalex.org/W296989292","https://openalex.org/W1521031730","https://openalex.org/W1655589213","https://openalex.org/W1966635880","https://openalex.org/W1997444760","https://openalex.org/W2004179925","https://openalex.org/W2015087988","https://openalex.org/W2065323160","https://openalex.org/W2067686417","https://openalex.org/W2069726169","https://openalex.org/W2090324990","https://openalex.org/W2096875748","https://openalex.org/W2109083102","https://openalex.org/W2117487024","https://openalex.org/W2134939120","https://openalex.org/W2140288698","https://openalex.org/W2165671231","https://openalex.org/W2231804640","https://openalex.org/W2232933692","https://openalex.org/W2418558247","https://openalex.org/W2507900361","https://openalex.org/W2512819857","https://openalex.org/W2584711061","https://openalex.org/W2770319189","https://openalex.org/W2794587166","https://openalex.org/W2889071092","https://openalex.org/W2903337332","https://openalex.org/W2907382363","https://openalex.org/W2909614706","https://openalex.org/W2969342955","https://openalex.org/W3015123576","https://openalex.org/W3038710321","https://openalex.org/W3049256810","https://openalex.org/W3080279557","https://openalex.org/W3112505688","https://openalex.org/W3119281176","https://openalex.org/W3127131093","https://openalex.org/W3181777473","https://openalex.org/W3216278892","https://openalex.org/W4220713990","https://openalex.org/W4225390784","https://openalex.org/W4308369850","https://openalex.org/W4377134017","https://openalex.org/W4406054872","https://openalex.org/W4411236801","https://openalex.org/W7147426389"],"related_works":[],"abstract_inverted_index":{"SR-17018":[0,50,77,97,122,154,172,216],"was":[1],"identified":[2],"as":[3],"a":[4,55,142,187],"highly":[5],"G":[6],"protein-biased":[7],"signaling":[8],"mu":[9],"opioid":[10,242],"peptide":[11],"(MOP)":[12],"receptor":[13,133,183],"agonist":[14,194],"with":[15,51,180,199],"an":[16,174],"improved":[17],"side-effect":[18],"profile":[19,25,178,223],"in":[20,26,43,175],"mice;":[21],"however,":[22],"its":[23,220,225],"functional":[24,177],"translationally":[27],"relevant":[28],"primate":[29,197,233],"models":[30,234],"remains":[31],"unknown.":[32],"Using":[33],"rhesus":[34],"monkeys":[35],"(":[36],"Macaca":[37],"mulatta":[38],"),":[39],"we":[40],"compared":[41],"the":[42,136,192,208,211,230,237],"vivo":[44,176],"effects":[45],"of":[46,57,130,215,232,240],"spinal":[47],"and":[48,62,71,86,114,123,202,224],"systemic":[49],"MOP":[52,132,182],"agonists":[53],"spanning":[54],"range":[56],"intrinsic":[58,213],"efficacies\u2014DAMGO,":[59],"morphine,":[60,115],"heroin,":[61],"buprenorphine\u2014using":[63],"behavioral":[64],"assays":[65,198],"for":[66,235],"nociception,":[67],"itch-scratching,":[68],"operant":[69],"reinforcement,":[70],"respiratory":[72],"depression.":[73],"Following":[74],"intrathecal":[75,121],"administration,":[76],"(30\u2013300":[78],"\u00b5g),":[79,82,85],"buprenorphine":[80,124,158,195],"(3\u201310":[81],"morphine":[83,103],"(10\u201330":[84],"DAMGO":[87,105,113],"(1\u20133":[88],"\u00b5g)":[89],"each":[90],"dose-dependently":[91],"attenuated":[92,221],"capsaicin-induced":[93],"thermal":[94],"allodynia,":[95],"although":[96],"required":[98],"substantially":[99],"higher":[100],"doses":[101],"than":[102,152,166,186],"or":[104,157],"to":[106,112],"achieve":[107],"comparable":[108],"antinociception.":[109],"In":[110,135],"contrast":[111],"which":[116,161],"elicited":[117],"robust":[118],"itch-scratching":[119],"responses,":[120],"produced":[125],"only":[126],"mild":[127],"scratching,":[128],"indicative":[129],"low":[131,181],"efficacy.":[134],"intravenous":[137],"drug":[138],"self-administration":[139],"assay":[140],"under":[141],"progressive-ratio":[143],"schedule,":[144],"heroin":[145],"(0.3\u201310":[146],"\u03bcg/kg/infusion)":[147,156,160],"generated":[148,162],"greater":[149,163],"reinforcing":[150,164],"strength":[151,165],"either":[153],"(3\u201330":[155],"(1\u201310":[159],"saline.":[167],"These":[168],"findings":[169],"demonstrate":[170],"that":[171,210],"exhibits":[173],"consistent":[179],"efficacy":[184,214],"rather":[185],"high-efficacy":[188],"agonist,":[189],"closely":[190],"resembling":[191],"partial":[193],"across":[196],"established":[200],"clinical":[201],"translational":[203,238],"relevance.":[204],"Our":[205],"results":[206],"support":[207],"conclusion":[209],"reduced":[212],"likely":[217],"underlies":[218],"both":[219],"adverse-effect":[222],"diminished":[226],"abuse":[227],"liability,":[228],"emphasizing":[229],"importance":[231],"defining":[236],"properties":[239],"novel":[241],"ligands.":[243]},"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-11-12T00:00:00"}